Top Texas Biotech Companies (137)
NovoThelium is a biotechnology company developing a tissue-engineered nipple matrix for use in breast reconstruction.
The UK Centre for Ecology & Hydrology (UKCEH) is an independent, not-for-profit research institute. Our scientists provide the data and insights that researchers, governments and businesses need to create a productive, resilient and healthy environment. We produce environmental science for a world where people and nature prosper
Colossal is a breakthrough bioscience and genetic engineering company that builds radical new technologies to advance the field of genomics. Colossal creates disruptive technologies for extinct species restoration, critically endangered species protection and the repopulation of critical ecosystems that support the continuation of life on Earth. The company is the first to apply CRISPR technology for the purposes of species...
BioPharma research company with ground breaking treatment for Therapy Resistant Metastatic Breast Cancer.
Neurolink is an early-stage company developing a novel therapy for the treatment of epilepsy.
Caris Life Sciences was founded in 2008 with a simple but powerful purpose – to help improve the lives of as many people as possible. With transformative technologies informed by massive amounts of big data, we are revolutionizing healthcare to provide physicians and patients with the highest quality information about their disease – from detecting it early and determining how...
Hera Biotech is a biotechnology company that is mainly developed for women's health and reproductive medicines.
Iterion Therapeutics is a venture-backed, clinical-stage biotechnology company that develops novel targeted cancer therapeutics.
Solis Mammography is a specialized healthcare provider that has been dedicated to helping women achieve and maintain breast health and peace of mind for more than 30 years and more than 5 million procedures. Headquartered in Addison, Texas, Solis operates 85 centers in nine major markets, including North Texas, Houston, Denver, Phoenix, Chicago, Philadelphia, Columbus, Nashville and Greensboro, and, through...
CECO Environmental is a global leader in air quality and fluid handling serving the energy, industrial and other niche markets. Providing innovative technology and application expertise, CECO helps companies grow their business with safe, clean and more efficient solutions that help protect our shared environment. In regions around the world, CECO works to improve air quality, optimize the energy value...
ImmunoMet Therapeutics is a biopharmaceutical company that develops and commercializes oncology products for cancer patients.
We are a global manufacturer of raw materials and a producer of energy used in everyday life. From medicines to mobile phones, agriculture to automotive, our products enhance standards of living for everyone around the world. We understand the challenge the world is facing, and we are working hard to help economies, businesses and individuals deliver a zero carbon emissions...
Stryker is a global leader in medical technologies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in MedSurg, Neurotechnology, Orthopaedics and Spine that help improve patient and healthcare outcomes. Alongside its customers around the world, Stryker impacts more than 130 million patients annually. More information is available at www.stryker.com. Together with...
Family Tree DNA is a genetic genealogy-based company focused on Y chromosome, autosomal, and mitochondrial ancestry DNA testing.
Scout Clinical’s mission is to make it easier for patients to participate in clinical trials. From travel arrangements and payment management to regulatory review and special services, we do it all.
Aggredyne is a biomedical company developing diagnostic devices for platelet therapy.
Tvardi is a clinical stage, private biotechnology company developing a new class of breakthrough medicines for diverse cancers.
NeuScience uses computer vision to detect phenotypic signals, resulting in novel, pan-cancer biomarkers.
